Dual action Smac mimetics–zinc chelators as pro-apoptotic antitumoral agents
- 1 October 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (19) , 4613-4619
Abstract
No abstract availableKeywords
Funding Information
- MIUR
This publication has 17 references indexed in Scilit:
- Synthesis and biological evaluation of dual actioncyclo-RGD/SMAC mimetic conjugates targeting αvβ3/αvβ5integrins and IAP proteinsOrganic & Biomolecular Chemistry, 2014
- Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapyBioorganic & Medicinal Chemistry, 2009
- Cyclic RGD‐Containing Functionalized Azabicycloalkane Peptides as Potent Integrin Antagonists for Tumor TargetingChemMedChem, 2009
- Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosisCell Death & Differentiation, 2008
- Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAPJournal of the American Chemical Society, 2007
- IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent ApoptosisCell, 2007
- Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulationBiochemical Pharmacology, 2003
- Taxol ResistanceChemotherapy, 2000
- Structural and biochemical basis of apoptotic activation by Smac/DIABLONature, 2000
- Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP InhibitionCell, 2000